Cannabis sativa and Fluid retention - a phase IV clinical study of FDA data
Summary:
Fluid retention is reported as a side effect among people who take Cannabis sativa (marijuana), especially for people who are female, 50-59 old, also take Pantoprazole, and have Relapsing-remitting multiple sclerosis.
The phase IV clinical study analyzes which people have Fluid retention when taking Cannabis sativa. It is created by eHealthMe based on reports of 8,561 people who have side effects when taking Cannabis sativa from the FDA, and is updated regularly.
What is Cannabis sativa?
Cannabis sativa has active ingredients of marijuana. eHealthMe is studying from 8,631 Cannabis sativa users. Check the latest studies of Cannabis sativa.
What is Fluid retention?
Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,702 drugs and 2,443 conditions by eHealthMe. Check the latest studies of Fluid retention.
8,561 people reported to have side effects when taking Cannabis sativa.
Among them, 57 people (0.67%) have Fluid retention.

Among these 57 people:
What is the gender of people who have Fluid retention when taking Cannabis sativa? *
- female: 79.17 %
- male: 20.83 %
What is the age of people who have Fluid retention when taking Cannabis sativa? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 80.43 %
- 60+: 19.57 %
What are other drugs people take besides Cannabis sativa? *
- Pantoprazole: 30 people, 52.63%
- Ocrevus: 29 people, 50.88%
- Folic Acid: 26 people, 45.61%
- Ibuprofen: 20 people, 35.09%
- Albuterol: 20 people, 35.09%
- Oxycodone: 19 people, 33.33%
- Triamcinolone Acetonide: 17 people, 29.82%
- Novalgin: 15 people, 26.32%
- Ramipril: 13 people, 22.81%
- Nitrofurantoin: 13 people, 22.81%
What are other side effects people have besides Fluid retention? *
- Weakness: 51 people, 89.47%
- Mobility Decreased (ability to move is reduced): 42 people, 73.68%
- Rashes (redness): 39 people, 68.42%
- Bone Pain: 39 people, 68.42%
- Cataract (clouding of the lens inside the eye): 38 people, 66.67%
- Irritability: 38 people, 66.67%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 38 people, 66.67%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 38 people, 66.67%
- Cushing's Syndrome (obesity, a rounded face, increased fat): 38 people, 66.67%
- Hair Loss: 38 people, 66.67%
What are the existing conditions these people have? *
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 31 people, 54.39%
- Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 12 people, 21.05%
- Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 12 people, 21.05%
- Urinary Tract Infection: 8 people, 14.04%
- Nasopharyngitis (inflammation of the nasopharynx): 8 people, 14.04%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 10.53%
- Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 6 people, 10.53%
- Progressive Relapsing Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both): 5 people, 8.77%
- Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 3 people, 5.26%
- Growth Hormone Deficiency: 3 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Cannabis sativa and have Fluid retention?
- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cannabis sativa:
- Cannabis sativa (8,631 reports)
Fluid retention treatments and more:
- Fluid retention (79,660 reports)
How severe was Fluid retention and when was it recovered:
Expand to all the drugs that have ingredients of marijuana:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cannabis sativa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Fluid retention:
- Fluid retention (1,702 drugs)
Browse all the conditions that are associated with Fluid retention:
- Fluid retention (2,443 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on marijuana (the active ingredients of Cannabis sativa) and Cannabis sativa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Calcium Gluconate cause Dyspnea? - 23 seconds ago
- Drug interactions of Propranolol Hydrochloride and Finasteride - 27 seconds ago
- Drug interactions of Entecavir and Lenvatinib - 30 seconds ago
- Acromegaly and Parkinson'S Disease - 33 seconds ago
- Could Gleevec cause Hepatotoxicity Aggravated? - 34 seconds ago
- Partial Seizures and Joint Injury - 38 seconds ago
- Drug interactions of Aricept and Tecfidera - 44 seconds ago
- Could Toprol-Xl cause Gastritis? - 46 seconds ago
- Drug interactions of Darvocet and Indomethacin - 46 seconds ago
- Drug interactions of Etodolac and Darvocet-N 100 - 59 seconds ago